Bio Essence (BIOE) Accounts Payables (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Accounts Payables of $3124.0 in Q1 2026, down 91.29% quarter-over-quarter from $35854.0 in Q4 2025, and down 99.09% on a YoY basis from $344419.0 in Q1 2025.
Bio Essence (BIOE) Accounts Payables (2020 - 2026) Analysis & Trends
Bio Essence's Accounts Payables history runs 7 years deep, the most recent figure standing at $3124.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 99.09% year-over-year to $3124.0; the TTM figure through Mar 2026 stood at $3124.0 (down 99.09% YoY), while the FY2025 annual figure was $35854.0, down 89.4% from the prior year.
- Accounts Payables was $3124.0 for Q1 2026 at Bio Essence, down from $35854.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $687045.0 in Q4 2022 to a low of $3124.0 in Q1 2026.
- Historically, Accounts Payables has averaged $183694.6 across 5 years, with a median of $105851.0 in 2022.
- The sharpest annual moves came in 2022 and 2026: Accounts Payables jumped 1542.04% in 2022, then sank 99.09% in 2026.
- A 5-year view of Accounts Payables shows it stood at $687045.0 in 2022, then tumbled by 79.96% to $137700.0 in 2023, then soared by 145.56% to $338136.0 in 2024, then tumbled by 89.4% to $35854.0 in 2025, then sank by 91.29% to $3124.0 in 2026.
- The last three Accounts Payables figures came in at $3124.0 (Q1 2026), $35854.0 (Q4 2025), and $5725.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | 3,124.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,124.00 |
| Dec 31, 2025 | 35,854.00 |
| Sep 30, 2025 | 5,725.00 |
| Jun 30, 2025 | 337,325.00 |
| Mar 31, 2025 | 344,419.00 |
| Dec 31, 2024 | 338,136.00 |
| Sep 30, 2024 | 336,604.00 |
| Jun 30, 2024 | 334,997.00 |
| Mar 31, 2024 | 183,170.00 |
| Dec 31, 2023 | 137,700.00 |
| Sep 30, 2023 | 56,534.00 |
| Jun 30, 2023 | 57,783.00 |
| Mar 31, 2023 | 41,841.00 |
| Dec 31, 2022 | 687,045.00 |
| Sep 30, 2022 | 73,329.00 |
| Jun 30, 2022 | 43,371.00 |
| Mar 31, 2022 | 105,851.00 |
| Dec 31, 2021 | 41,841.00 |
| Sep 30, 2021 | 58,128.00 |
| Jun 30, 2021 | 62,981.00 |